Compare · SPAI vs STE
SPAI vs STE
Side-by-side comparison of Safe Pro Group Inc. (SPAI) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SPAI and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.08B, about 267.7x SPAI ($78.8M).
- Over the past year, SPAI is up 18.2% and STE is down 4.3% - SPAI leads by 22.5 points.
- SPAI has been more active in the news (6 items in the past 4 weeks vs 1 for STE).
- STE has more recent analyst coverage (16 ratings vs 1 for SPAI).
- Company
- Safe Pro Group Inc.
- STERIS plc (Ireland)
- Price
- $3.79-2.94%
- $215.89-0.03%
- Market cap
- $78.8M
- $21.08B
- 1M return
- -27.02%
- +1.48%
- 1Y return
- +18.22%
- -4.30%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 6
- 1
- Recent ratings
- 1
- 16
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest SPAI
- Autonomous Underwater Vehicles (AUV) Emerging as Fastest-Growing Segment in Naval Defense Tech
- Chief Growth Officer Mack Brian William was granted 300,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Mack Brian William
- Safe Pro Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Safe Pro Awarded New $1.3 Million U.S. Government Subcontract to Integrate Real-Time AI Landmine Detection into Unmanned Ground Vehicles
- Safe Pro Awarded New $1.3 Million U.S. Army Subcontract to Integrate Real-Time AI Landmine Detection into Unmanned Ground Vehicles
- Safe Pro Contracted to Provide U.S. Army Edge AI Operational Support for Airfield Exercise, Expanding its Role in Force Protection Applications
- Chief Operating Officer Mathews Jarret Daniel was granted 20,000 shares, increasing direct ownership by 160% to 32,500 units (SEC Form 4)
- New insider Mathews Jarret Daniel claimed ownership of 12,500 shares (SEC Form 3)
- Safe Pro Executes on $742,000 U.S. Army Award Rapidly Delivering AI Edge Processing NODE and Red Cat Black Widow Drones
Latest STE
- Director Sohi Mohsen exercised 3,781 units of Ordinary Shares at a strike of $71.40 and covered exercise/tax liability with 1,837 units of Ordinary Shares, increasing direct ownership by 9% to 24,305 units (SEC Form 4)
- SEC Form 11-K filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam sold $296,968 worth of Ordinary Shares (1,419 units at $209.28), decreasing direct ownership by 4% to 35,259 units (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)